Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
SRPT - STOCK-BASED COMPENSATION
Stock-based Compensation SRPT - Sarepta Therapeutics, Inc.
183 M
LAST VALUE
26.56%
2 YEAR CAGR
29.49%
5 YEAR CAGR
32.28%
10 YEAR CAGR